National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 333083

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2008

VAERS ID: 333083
VAERS Form:
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 - / PO

Administered by: Other      Purchased by: Unknown
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type':

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileo"colic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema fail


Changed on 12/8/2009

VAERS ID: 333083 Before After
VAERS Form:
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 - / PO

Administered by: Other      Purchased by: Unknown Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': (blank) WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileo"colic ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema fail failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 5/13/2013

VAERS ID: 333083 Before After
VAERS Form:
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 - / PO
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 9/14/2017

VAERS ID: 333083 Before After
VAERS Form:(blank) 1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 1 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 2/14/2018

VAERS ID: 333083 Before After
VAERS Form:1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 6/14/2018

VAERS ID: 333083 Before After
VAERS Form:1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 8/14/2018

VAERS ID: 333083 Before After
VAERS Form:1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 9/14/2018

VAERS ID: 333083 Before After
VAERS Form:1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.


Changed on 10/14/2018

VAERS ID: 333083 Before After
VAERS Form:1
Age:0.2
Sex:Male
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2008-11-21
Entered:2008-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Intussusception, Surgery, Enema administration, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, contrast enema failed to reduce; ultrasound, ileocolic intussusception
CDC 'Split Type': WAES0811USA02627

Write-up: Information has been received from an investigator concerning a 2 month old male who was vaccinated PO with his first dose of ROTATEQ. This report was part of a post-marketing surveillance program. Seven days after vaccination the patient experienced ileocolic intussusception and was hospitalized for 2 days. Two days prior to admission the patient experienced crampy abdominal pain. Laboratory diagnostic studies included an ultrasonography which verified the ileocolic intussusception. A contrast enema failed to reduce the intussusception, however; it was reduced surgically. The patient was discharged from the hospital on day and the outcome was unknown. At this time, relationship of ileocolic intussusception to study therapy is unknown. Ileocolic intussusception was considered to be an other important medical event (surgery) by the reporter. Additional information has been requested.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=333083&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166